C4 Therapeutics Inc. Revenue 2021–2025
C4 Therapeutics Inc. annual/quarterly revenue history and growth rate from 2021 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- C4 Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 6.2 M, a 15.00% decrease year-over-year.
- C4 Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 31.1 M, a 25.06% decrease year-over-year.
- C4 Therapeutics Inc. annual revenue for 2025 was 35.9 M, a 1.02% increase from 2024.
- C4 Therapeutics Inc. annual revenue for 2024 was 35.6 M, a 71.44% increase from 2023.
- C4 Therapeutics Inc. annual revenue for 2023 was 20.8 M, a 33.25% decrease from 2022.
- C4 Therapeutics Inc. annual revenue for 2022 was 31.1 M.
C4 Therapeutics Inc. (CCCC) — Frequently Asked Questions
C4 Therapeutics Inc. (CCCC) is a publicly traded US company. It has a market capitalization of $316M. In fiscal 2025 it reported revenue of $36M and net income of -$105M. Explore CCCC's stock price, financial statements, earnings history, margins and key ratios below.
What is C4 Therapeutics Inc.'s market cap?
C4 Therapeutics Inc. (CCCC) has a market capitalization of $316M.
What is the CCCC stock price?
CCCC trades at $3.81 (-1.55% on the day).
How much revenue does C4 Therapeutics Inc. make?
C4 Therapeutics Inc. reported revenue of $36M in fiscal 2025.
Is CCCC profitable?
In fiscal 2025, C4 Therapeutics Inc. reported net income of -$105M.